2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference, Critical Care Medicine, vol.31, issue.4, pp.1250-1256, 2001. ,
DOI : 10.1097/01.CCM.0000050454.01978.3B
The Epidemiology of Sepsis in the United States from 1979 through 2000, New England Journal of Medicine, vol.348, issue.16, pp.1546-1554, 2000. ,
DOI : 10.1056/NEJMoa022139
Current Epidemiology of Septic Shock, American Journal of Respiratory and Critical Care Medicine, vol.168, issue.2, pp.165-172, 2003. ,
DOI : 10.1164/rccm.2201087
Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care, Critical Care Medicine, vol.29, issue.7, pp.1303-1310, 2001. ,
DOI : 10.1097/00003246-200107000-00002
Outcomes of the Surviving Sepsis Campaign in intensive care units in the USA and Europe: a prospective cohort study, The Lancet Infectious Diseases, vol.12, issue.12, pp.919-943, 2012. ,
DOI : 10.1016/S1473-3099(12)70239-6
Inflammation locale et générale « Sepsis, pp.45-73, 2004. ,
Vascular nitric oxide during sepsis: from deficiency to overproduction Adv, Sepsis, vol.1, pp.52-57, 2001. ,
Bench-to-bedside review: microvascular dysfunction in sepsishemodynamics , oxygen transport, and nitric oxide Crit, Care, vol.7, pp.359-373, 2003. ,
Genetic Polymorphisms in Sepsis and Septic Shock, Chest, vol.124, issue.3, pp.1103-1118, 2003. ,
DOI : 10.1378/chest.124.3.1103
The role of ICAM-1 in endotoxin-induced acute renal failure, AJP: Renal Physiology, vol.293, issue.4, pp.1262-1271, 2007. ,
DOI : 10.1152/ajprenal.00445.2006
Sepsis in European intensive care units: Results of the SOAP study*, Occurrence in Acutely Ill Patients Investigators, pp.344-353, 2006. ,
DOI : 10.1097/01.CCM.0000194725.48928.3A
Early Goal-Directed Therapy in the Treatment of Severe Sepsis and Septic Shock, New England Journal of Medicine, vol.345, issue.19, pp.1368-77, 2001. ,
DOI : 10.1056/NEJMoa010307
Bench-to-bedside review: microvascular dysfunction in sepsis -hemodynamics, oxygen transport, and nitric oxide, Critical Care, vol.7, issue.5, pp.359-73, 2003. ,
DOI : 10.1186/cc2353
Profound but Reversible Myocardial Depression in Patients with Septic Shock, Annals of Internal Medicine, vol.100, issue.4, pp.483-90, 1984. ,
DOI : 10.7326/0003-4819-100-4-483
Persistent Preload Defect in Severe Sepsis Despite Fluid Loading, Chest, vol.116, issue.5, pp.1354-1363, 1999. ,
DOI : 10.1378/chest.116.5.1354
Vascular reactivity and tissue oxygenation, Intensive Care Medicine, vol.24, issue.1, pp.3-11, 1998. ,
DOI : 10.1007/s001340050507
Acute Renal Failure and Sepsis, New England Journal of Medicine, vol.351, issue.2, pp.159-169, 2004. ,
DOI : 10.1056/NEJMra032401
Insuffisance r??nale aigu????: ??pid??miologie, incidence et facteurs de risque, Annales Fran??aises d'Anesth??sie et de R??animation, vol.24, issue.2, pp.134-143, 2005. ,
DOI : 10.1016/j.annfar.2004.11.017
Acute Renal Failure in Critically Ill Patients<SUBTITLE>A Multinational, Multicenter Study</SUBTITLE>, JAMA, vol.294, issue.7, pp.813-818, 2005. ,
DOI : 10.1001/jama.294.7.813
The enigma of sepsis, Journal of Clinical Investigation, vol.112, issue.4, pp.460-467, 2003. ,
DOI : 10.1172/JCI200319523
The Natural History of the Systemic Inflammatory Response Syndrome (SIRS), JAMA, vol.273, issue.2, pp.117-140, 1995. ,
DOI : 10.1001/jama.1995.03520260039030
Effect of endotoxemia on hypoxic pulmonary vasoconstriction in unanesthetized sheep, J Appl Physiol, vol.58, pp.1463-1468, 1985. ,
Surviving Sepsis Campaign, Critical Care Medicine, vol.41, issue.2, pp.536-555, 2012. ,
DOI : 10.1097/CCM.0b013e31827e83af
Initiation of Inappropriate Antimicrobial Therapy Results in a Fivefold Reduction of Survival in Human Septic Shock, Chest, vol.136, issue.5, pp.1237-1248, 2009. ,
DOI : 10.1378/chest.09-0087
Effect of acute renal failure requiring renal replacement therapy on outcome in critically ill patients*, Critical Care Medicine, vol.30, issue.9, pp.2051-2059, 2002. ,
DOI : 10.1097/00003246-200209000-00016
Intensive Insulin Therapy and Pentastarch Resuscitation in Severe Sepsis, New England Journal of Medicine, vol.358, issue.2, pp.125-164, 2008. ,
DOI : 10.1056/NEJMoa070716
Assessment of hemodynamic efficacy and safety of 6% hydroxyethylstarch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: The CRYSTMAS study, Critical Care, vol.16, issue.3, p.94, 2012. ,
DOI : 10.1186/1745-6215-12-24
URL : https://hal.archives-ouvertes.fr/inserm-00706029
Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock*, Critical Care Medicine, vol.34, issue.6, pp.1589-1596, 2006. ,
DOI : 10.1097/01.CCM.0000217961.75225.E9
Early combination antibiotic therapy yields improved survival compared with monotherapy in septic shock: A propensity-matched analysis*, Critical Care Medicine, vol.38, issue.9, pp.1773-85, 2010. ,
DOI : 10.1097/CCM.0b013e3181eb3ccd
Hydroxyethyl Starch 130/0.42 versus Ringer's Acetate in Severe Sepsis, New England Journal of Medicine, vol.367, issue.2, pp.124-158, 2012. ,
DOI : 10.1056/NEJMoa1204242
Hydroxyethyl Starch or Saline for Fluid Resuscitation in Intensive Care, New England Journal of Medicine, vol.367, issue.20, pp.1901-1912, 2012. ,
DOI : 10.1056/NEJMoa1209759
Intensive Insulin Therapy in Critically Ill Patients, New England Journal of Medicine, vol.345, issue.19, pp.1359-1367, 2001. ,
DOI : 10.1056/NEJMoa011300
Diagnostic et antibiothérapies des infections urinaires bactériennes communautaires chez l'adulte ? Affsaps, 2008. ,
beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for fever with neutropenia: systematic review and meta-analysis, BMJ, vol.326, issue.7399, pp.1111-1116, 2003. ,
DOI : 10.1136/bmj.326.7399.1111
My Life with the Microbes, Soil Science, vol.79, issue.3, pp.214-245, 1954. ,
DOI : 10.1097/00010694-195503000-00033
Streptomycin, a Substance Exhibiting Antibiotic Activity Against Gram-Positive and Gram-Negative Bacteria.*??, Experimental Biology and Medicine, vol.55, issue.1, pp.66-75, 1944. ,
DOI : 10.3181/00379727-55-14461
Effect of Streptomycin and Other Antibiotic Substances upon Mycobacterium tuberculosis and Related Organisms.,, Experimental Biology and Medicine, vol.57, issue.2, pp.244-252, 1944. ,
DOI : 10.3181/00379727-57-14769
Streptomycin: background, isolation, properties, and utilization. Nobel lecture December 12th, 1952. Nobel Lectures, Physiology or Medicine, 1942. ,
DOI : 10.1126/science.118.3062.259
Neomycin, a New Antibiotic Active against Streptomycin-Resistant Bacteria, including Tuberculosis Organisms, Science, vol.109, issue.2830, pp.305-307, 1949. ,
DOI : 10.1126/science.109.2830.305
Production and isolation of a new antibiotic, kanamycin, J Antibiot (Tokyo), vol.10, pp.181-189, 1957. ,
a New Antibiotic Complex from Micromonospora, Journal of Medicinal Chemistry, vol.6, issue.4, pp.463-464, 1963. ,
DOI : 10.1021/jm00340a034
In Vitro Comparison of Netilmicin, a Semisynthetic Derivative of Sisomicin, and Four Other Aminoglycoside Antibiotics, Antimicrobial Agents and Chemotherapy, vol.10, issue.1, pp.139-145, 1976. ,
DOI : 10.1128/AAC.10.1.139
Nebramycin, a new broad-spectrum antibiotic complex ,
BB-K8, A NEW SEMISYNTHETIC AMINOGLYCOSIDE ANTIBIOTIC, The Journal of Antibiotics, vol.25, issue.12, p.695, 1972. ,
DOI : 10.7164/antibiotics.25.695
Killing and regrowth of bacteria in vitro: a review, Scand J Infect Dis, vol.74, pp.63-70, 1990. ,
Clinical Response to Aminoglycoside Therapy: Importance of the Ratio of Peak Concentration to Minimal Inhibitory Concentration, Journal of Infectious Diseases, vol.155, issue.1, pp.93-102, 1987. ,
DOI : 10.1093/infdis/155.1.93
Optimizing aminoglycosides therapy for nosocomial pneumonia caused by Gram-negative bacteria, Antimicrob Agents Chemother, vol.43, pp.623-632, 1999. ,
Postantibiotic effect of aminogylcosides on staphylococci, Journal of Antimicrobial Chemotherapy, vol.32, issue.2, pp.215-237, 1993. ,
DOI : 10.1093/jac/32.2.215
Postantibiotic effect of aminoglycosides on Gram-negative bacteria evaluated by a new method, Journal of Antimicrobial Chemotherapy, vol.22, issue.1, pp.23-33, 1988. ,
DOI : 10.1093/jac/22.1.23
Postantibiotic effect in Pseudomonas aeruginosa following single and multiple aminoglycoside exposures in vitro, J Antimicrob Chemother, vol.33, issue.5, pp.937-984, 1994. ,
Aminoglycoside-Resistance Mechanisms in Multidrug-Resistant Staphylococcus aureus Clinical Isolates, Current Microbiology, vol.36, issue.6, pp.558-62, 2008. ,
DOI : 10.1007/s00284-008-9123-y
Aminoglycosides: nephrotoxicity, Antimicrob Agents Chemother, vol.43, pp.1003-1015, 1999. ,
Optimizing Use of Aminoglycosides in the Critically Ill, Seminars in Respiratory and Critical Care Medicine, vol.28, issue.6, pp.596-603, 2007. ,
DOI : 10.1055/s-2007-996406
Back to the future: using aminoglycosides again and how to dose them optimally, Clin Infect Dis, vol.45, pp.753-60, 2007. ,
Aminoglycoside toxicity - a review of clinical studies published between 1975 and 1982, Journal of Antimicrobial Chemotherapy, vol.13, issue.suppl A, pp.9-22, 1984. ,
DOI : 10.1093/jac/13.suppl_A.9
Bases pharmacocinétique de l'ototoxicité des aminosides. Comment définir le rythme optimal d'administration des aminoglycosides, pp.39-42, 1989. ,
Does once daily dosing prevent nephrotoxicity in all aminoglycosides? Clinical Microbiology and Infection: the official publication of the European Society of, Clinical Microbiology and Infectious Diseases, vol.6, issue.7, pp.357-62, 2000. ,
Aminoglycoside antibiotics traffic to the Golgi complex in LLC-PK1 cells, J Am Soc Nephrol, vol.9, pp.167-174, 1998. ,
Early effects of gentamicin, tobramycin, and amikacin on the human kidney, Kidney International, vol.25, issue.4, pp.643-52, 1984. ,
DOI : 10.1038/ki.1984.69
Isepamicin in intensive care unit patients with nosocomial pneumonia: population pharmocokinetic-pharmacodynamic study, The journal of antimicrobial chemotherapy, vol.44, issue.1, pp.99-108, 1999. ,
Once-daily dosing of aminoglycosides, European Journal of Clinical Microbiology & Infectious Diseases, vol.17, issue.Supplement 3, pp.1029-1067, 1995. ,
DOI : 10.1007/BF01590935
Single Daily Dosing of Aminoglycosides in Immunocompromised Adults: A Systematic Review, Clinical Infectious Diseases, vol.24, issue.5, pp.810-815, 1997. ,
DOI : 10.1093/clinids/24.5.810
Influence of dosage Schedule on renal accumulation of amikacin and tobramycin in man. The journal of antim chemotherapy, pp.41-48, 1991. ,
Once-daily dosing decrease accumulation of gentamicin and netilmicin. Clinical pharmacology and therapeutic, pp.22-29 ,
Aminoglycoside Nephrotoxicity: Modeling, Simulation, and Control, Antimicrobial Agents and Chemotherapy, vol.47, issue.3, pp.1010-1016, 2003. ,
DOI : 10.1128/AAC.47.3.1010-1016.2003
URL : https://hal.archives-ouvertes.fr/hal-00427460
Once-daily gentamicin versus once-daily netilmicin in patients with serious infections???a randomized clinical trial, Journal of Antimicrobial Chemotherapy, vol.33, issue.4, pp.823-858, 1994. ,
DOI : 10.1093/jac/33.4.823
Single or multiple daily doses of aminoglycosides: a meta- analysis, BMJ, vol.312, issue.7027, pp.338-383, 1996. ,
DOI : 10.1136/bmj.312.7027.338
A Meta-Analysis of the Relative Efficacy and Toxicity of Single Daily Dosing Versus Multiple Daily Dosing of Aminoglycosides, Clinical Infectious Diseases, vol.24, issue.5, pp.796-809, 1997. ,
DOI : 10.1093/clinids/24.5.796
Once versus multiple daily dosing of aminoglycosides for patients with febrile neutropenia: a systematic review and meta-analysis, Journal of Antimicrobial Chemotherapy, vol.66, issue.2, pp.251-260, 2011. ,
DOI : 10.1093/jac/dkq451
Bacteremia and Endocarditis Is Nephrotoxic, Clinical Infectious Diseases, vol.48, issue.6, pp.713-734, 2009. ,
DOI : 10.1086/597031
Severity of Gentamicin's Nephrotoxic Effect on Patients with Infective Endocarditis: A Prospective Observational Cohort Study of 373 Patients, Clinical Infectious Diseases, vol.48, issue.1, pp.65-71, 2009. ,
DOI : 10.1086/594122
Drug Administration in Patients with Renal Insufficiency Minimising Renal and Extrarenal Toxicity, Drug Safety, vol.16, issue.3, pp.205-236, 1997. ,
DOI : 10.2165/00002018-199716030-00005
Aminoglycoside volume of distribution and illness severity in critically ill septic patients, Anaesth Intensive Care, vol.21, pp.172-175, 1993. ,
Pharmacokinetic issues for antibiotics in the critically ill patient, Critical Care Medicine, vol.37, issue.3, pp.840-51, 2009. ,
DOI : 10.1097/CCM.0b013e3181961bff
Revisiting the loading dose of amikacin for patients with severe sepsis and septic shock, Critical Care, vol.14, issue.2, p.53, 2010. ,
DOI : 10.1186/cc8945
Management of Aminoglycosides in the Intensive Care Unit, Journal of Intensive Care Medicine, vol.25, issue.6, pp.327-369, 2010. ,
DOI : 10.1177/0885066610377968
Dosage des??antibiotiques en??r??animation??: quand et??comment demander et??interpr??ter les??tests???, R??animation, vol.15, issue.3, pp.187-92, 2006. ,
DOI : 10.1016/j.reaurg.2006.03.011
Antibiotic dosing in critical illness, Journal of Antimicrobial Chemotherapy, vol.66, issue.Supplement 2, pp.25-31, 2011. ,
DOI : 10.1093/jac/dkq516
A suggested approach to once-daily aminoglycoside dosing., British Journal of Clinical Pharmacology, vol.56, issue.6, pp.605-614, 1995. ,
DOI : 10.1111/j.1365-2125.1995.tb05719.x
Aminoglycoside drugs in clinical practice: an evidence-based approach, Journal of Antimicrobial Chemotherapy, vol.63, issue.2, pp.246-51, 2009. ,
DOI : 10.1093/jac/dkn469
Clinical efficacy of IV once-daily dosing isepamicin used five or ten days, with or without initial loading dose in ICU, ICAAC, pp.39-371 ,
Guidelines on the prevention, and treatment of infective endocarditis: the task force on the prevention, diagnosis and treatment of infective endocarditis of the European Society of Cardiology (ESC), Eur Heart J, vol.30, pp.2369-413, 2009. ,
URL : https://hal.archives-ouvertes.fr/hal-00465409
Infections ostéoarticulaires sur matériel (prothèse,implant,ostéosynthèse)?Spilf, 2009. ,
Prise en charge du pied diabétique infecté ? Spilf, 2006. ,
Spondylodiscites infectieuses primitives et secondaires à un geste inra discal, sans mise en place de matériel ? Spilf, 2007. ,
Inappropriate prescribing of aminoglycosides: risk factors and impact of an antibiotic control team, Journal of Antimicrobial Chemotherapy, vol.58, issue.3, pp.651-657, 2006. ,
DOI : 10.1093/jac/dkl288
?? lactam monotherapy versus ?? lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomised trials, BMJ, vol.328, issue.7441, p.668, 2004. ,
DOI : 10.1136/bmj.38028.520995.63
Monotherapy or aminoglycoside-containing combinations for empirical antibiotic treatment of febrile neutropenic patients: a meta-analysis, The Lancet Infectious Diseases, vol.2, issue.4, pp.231-273, 2002. ,
DOI : 10.1016/S1473-3099(02)00241-4
Single versus combination intravenous antibiotic therapy for people with cystic fibrosis, Cochrane Database Syst Rev, issue.2, p.2007, 2005. ,
Does combination antimicrobial therapy reduce mortality in Gram-negative bacteraemia? A meta-analysis, The Lancet Infectious Diseases, vol.4, issue.8, pp.519-546, 2004. ,
DOI : 10.1016/S1473-3099(04)01108-9
Prospective observational study of Klebsiella bacteremia in 230 patients: outcome for antibiotic combinations versus monotherapy., Antimicrobial Agents and Chemotherapy, vol.36, issue.12, pp.2639-2683, 1992. ,
DOI : 10.1128/AAC.36.12.2639
Role of aminoglycosides in the treatment of bacterial endocarditis, Journal of Antimicrobial Chemotherapy, vol.49, issue.3 ,
DOI : 10.1093/jac/49.3.437
Ventilator-associated Pneumonia, American Journal of Respiratory and Critical Care Medicine, vol.165, issue.7, pp.867-903, 2002. ,
DOI : 10.1164/ajrccm.165.7.2105078
Monotherapy with a Broad-Spectrum Beta-Lactam Is as Effective as Its Combination with an Aminoglycoside in Treatment of Severe Generalized Peritonitis: a Multicenter Randomized Controlled Trial, Antimicrobial Agents and Chemotherapy, vol.44, issue.8, pp.2028-2061, 2000. ,
DOI : 10.1128/AAC.44.8.2028-2033.2000
Rotation and restricted use of antibiotics in a medical intensive care unit: impact on the incidence of ventilator-associated pneumonia caused by antibiotic-resistant gram-negative bacteria, Am J Respir Crit Care Med, vol.162, pp.837-843, 2000. ,
Renal tolerability of four different once-daily dose regimen of netilmicin in critical care patients, Wien Klin Wochenschr, vol.109, pp.840-844, 1997. ,
Prospective evaluation of the effect of an aminoglycoside dosing regimen on rates of observed nephrotoxicity and ototoxicity ,
, does not achieve desired serum concentration in critically ill patients with lowered creatinine clearance, Journal of Clinical Pharmacy and Therapeutics, vol.50, issue.5, pp.521-527, 2008. ,
DOI : 10.1111/j.1365-2710.2008.00947.x
Population Pharmacokinetics of Aminoglycosides in Critically Ill Trauma Patients on Once-Daily Regimens, The Journal of Trauma: Injury, Infection, and Critical Care, vol.49, issue.5, pp.869-872, 2000. ,
DOI : 10.1097/00005373-200011000-00013
Deafness and prolonged neuromuscular blockade following single-dose peritoneal neomycin irrigation, Canadian Journal of Anaesthesia, vol.54, issue.6, pp.568-570710, 1957. ,
DOI : 10.1007/BF03012710
Neuromuscular Blockade Associated With Gentamicin Therapy, JAMA: The Journal of the American Medical Association, vol.215, issue.7, pp.1153-1154, 1971. ,
DOI : 10.1001/jama.1971.03180200075022
Tobramycin-Curare Interaction, Anesthesia & Analgesia, vol.56, issue.4, pp.587-588, 1977. ,
DOI : 10.1213/00000539-197707000-00034
Does once-daily dosing of aminoglycosides affect neuromuscular function?, Journal of Clinical Pharmacy and Therapeutics, vol.7, issue.6, pp.407-411, 1996. ,
DOI : 10.1111/j.1365-2710.1996.tb00039.x
A model for predicting nephrotoxicity in patients treated with aminoglycosides. The Journal of infectious diseases, pp.1062-1070, 1986. ,
Risk factors for nephrotoxicity in patients treated with aminoglycosides. Annals of internal medicine, pp.352-359, 1984. ,
Can pharmacokinetic dosing decrease nephrotoxicity associated with aminoglycoside therapy, Journal of the American Society of Nephrology : JASN, vol.4, issue.1, pp.99-108, 1993. ,
Individualized Pharmacokinetic Monitoring Results in Less Aminoglycoside-Associated Nephrotoxicity and Fewer Associated Costs, Pharmacotherapy: Official Journal of the American College of Clinical Pharmacy, vol.13, issue.4, pp.443-51, 2001. ,
DOI : 10.1016/S0140-6736(78)92825-8
Gender differences in aminoglycoside induced nephrotoxicity: a prospective, hospital-based study. Current clinical pharmacology, pp.229-261, 2009. ,
Prevalence and Risk Factors for Aminoglycoside Nephrotoxicity in Intensive Care Units, Antimicrobial Agents and Chemotherapy, vol.53, issue.7, pp.2887-91, 2009. ,
DOI : 10.1128/AAC.01430-08
Aminoglycoside-associated nephrotoxicity in the elderly. The Annals of pharmacotherapy, pp.182-188, 2003. ,
Risk factors for the development of renal dysfunction in hospitalized patients with cirrhosis. The American journal of gastroenterology, pp.2206-2216, 2001. ,
Incidence of and Significant Risk Factors for Aminoglycoside-Associated Nephrotoxicity in Patients Dosed by Using Individualized Pharmacokinetic Monitoring, Journal of Infectious Diseases, vol.167, issue.1, pp.173-182, 1993. ,
DOI : 10.1093/infdis/167.1.173
Amikacin nephrotoxicity in patients with chronic liver disease Revista de investigacion clinica, Nutricion, vol.42, issue.2, pp.93-101, 1990. ,
New insights into the mechanism of aminoglycoside nephrotoxicity: an integrative point of view, Kidney International, vol.79, issue.1, pp.33-45, 2011. ,
DOI : 10.1038/ki.2010.337
Endotoxemia, Renal Hypoperfusion, and Fever: Interactive Risk Factors for Aminoglycoside and Sepsis-Associated Acute Renal Failure, American Journal of Kidney Diseases, vol.20, issue.3, pp.223-253, 1992. ,
DOI : 10.1016/S0272-6386(12)80694-9
Low serum albumin and the increased risk of amikacin nephrotoxicity Revista de investigacion clinica, Nutricion, vol.46, issue.1, pp.37-43, 1994. ,
Once versus thrice daily gentamicin in patients with serious infections, The Lancet, vol.341, issue.8841, pp.335-344, 1993. ,
DOI : 10.1016/0140-6736(93)90137-6
Optimization of Aminoglycoside Therapy, Antimicrobial Agents and Chemotherapy, vol.55, issue.6, pp.2528-2559, 2011. ,
DOI : 10.1128/AAC.01314-10
Validation and nephrotoxicity of a simplified once-daily aminoglycoside dosing schedule and guidelines for monitoring therapy, Antimicrobial agents and chemotherapy, vol.40, issue.11, pp.2494-2503, 1996. ,
An overview of drug-induced acute kidney injury, Critical Care Medicine, vol.36, issue.Suppl, pp.216-239, 2008. ,
DOI : 10.1097/CCM.0b013e318168e375
Circadian variations in serum levels and the renal toxicity of aminoglycosides in patients, Clinical Pharmacology & Therapeutics, vol.158, issue.1, pp.106-117, 1997. ,
DOI : 10.1016/S0009-9236(97)90156-9
A meta-analysis of studies on the safety and efficacy of aminoglycosides given either once daily or as divided doses, Journal of Antimicrobial Chemotherapy, vol.37, issue.4, pp.645-63, 1996. ,
DOI : 10.1093/jac/37.4.645
Effect of Furosemide on the Pharmacokinetics of Gentamicin in Patients, The Journal of Clinical Pharmacology, vol.2, issue.5, pp.5-6254, 1982. ,
DOI : 10.1002/j.1552-4604.1982.tb02670.x
Effect of furosemide on aminoglycoside-induced nephrotoxicity and auditory toxicity in humans., Antimicrobial Agents and Chemotherapy, vol.23, issue.1, pp.133-140, 1983. ,
DOI : 10.1128/AAC.23.1.133
An assessment of the RIFLE criteria for acute renal failure in hospitalized patients*, Critical Care Medicine, vol.34, issue.7, pp.1913-1920, 2006. ,
DOI : 10.1097/01.CCM.0000224227.70642.4F
Acute renal failure definition, outcome measures, animal models, fluid therapy and information technology needs: the second international consensus conference of the acute dialysis quality initiative (ADQI) group, Critical Care, vol.8, issue.4, pp.204-212, 2004. ,
DOI : 10.1186/cc2872
A new simplified acute physiology score (SAPS II) based on a ,
North American multicenter study, JAMA, vol.270, pp.2957-2963, 1993. ,
Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units, Critical Care Medicine, vol.26, issue.11, pp.1793-800, 1998. ,
DOI : 10.1097/00003246-199811000-00016
Algorithm for assessing renal dysfunction risk in critically ill trauma patients receiving aminoglycosides, The American Journal of Surgery, vol.160, issue.5, pp.473-80, 1990. ,
DOI : 10.1016/S0002-9610(05)81007-4
Pharmacocinétique : Principes fondamentaux, 1984. ,
Pseudomonas aeruginosa infections in the Intensive Care Unit: can the adequacy of empirical beta-lactam antibiotic therapy be improved? International journal of antimicrobial agents, pp.458-62, 2007. ,
Using Local Microbiologic Data To Develop Institution-Specific Guidelines for the Treatment of Hospital-Acquired Pneumonia, Chest, vol.130, issue.3 ,
DOI : 10.1378/chest.130.3.787
Monitorage des aminosides en r??animation, M??decine et Maladies Infectieuses, vol.40, issue.2, pp.94-99, 2012. ,
DOI : 10.1016/j.medmal.2009.08.011
Clinical and bacteriological efficacy, and practical aspects of amikacin given once daily for severe infections, Journal of Antimicrobial Chemotherapy, vol.27, issue.suppl C, pp.91-103, 1991. ,
DOI : 10.1093/jac/27.suppl_C.91
Pharmacokinetics/pharmacodynamics of antibacterials in the Intensive Care Unit: setting appropriate dosing regimens, International Journal of Antimicrobial Agents, vol.32, issue.4, pp.294-301, 2008. ,
DOI : 10.1016/j.ijantimicag.2008.03.015
Gentamicin dosing in critically ill patients, Acta Anaesthesiologica Scandinavica, vol.12, issue.6, pp.734-774, 2001. ,
DOI : 10.1086/313692